Patient Square Capital is a healthcare investment firm managing approximately $8 billion as of December 31, 2023. It partners with leading management teams to support companies focused on health improvement. Leveraging extensive industry knowledge and a broad network, the firm helps businesses grow. Notable investments include Apollo Therapeutics, primarily in the biotech and pharma sectors. They typically invest during later stages, such as Series C. Patient Square Capital is committed to enhancing patient lives, strengthening communities, and creating a healthier world.
